Editorial
In vivo reprogramming of hepatic myofibroblasts into hepatocytes attenuates liver fibrosis: back to the future?
Stem Cell Investigation
2016;
3:
53
.
(29 September 2016)
Review Article
A review of Rett syndrome (RTT) with induced pluripotent stem cells
Stem Cell Investigation
2016;
3:
52
.
(28 September 2016)
Perspective
Epigenetic regulation of human DCLK-1 gene during colon-carcinogenesis: clinical and mechanistic implications
Stem Cell Investigation
2016;
3:
51
.
(28 September 2016)
Short Report
TET2 mutations were predictive of inferior prognosis in the presence of ASXL1 mutations in patients with chronic myelomonocytic leukemia
Stem Cell Investigation
2016;
3:
50
.
(23 September 2016)
Editorial
Intestinal stem cell resurgence by enterocyte precursors
Stem Cell Investigation
2016;
3:
49
.
(23 September 2016)
Case Report
Mesenchymal stem cell therapy for refractory scleroderma: a report of 2 cases
Stem Cell Investigation
2016;
3:
48
.
(19 September 2016)
Commentary
Divergent lncRNAs take the lead on pluripotent cell differentiation
Stem Cell Investigation
2016;
3:
47
.
(19 September 2016)
Commentary
Maintenance of hematopoietic stem cell dormancy: yet another role for the macrophage
Stem Cell Investigation
2016;
3:
46
.
(19 September 2016)
Commentary
Direct conversion of fibroblasts traces the way back to our first organ—the placenta
Stem Cell Investigation
2016;
3:
45
.
(19 September 2016)
Commentary
The DARC-CD82 axis discloses bone marrow macrophages as guardians of long-term hematopoietic stem cells quiescence
Stem Cell Investigation
2016;
3:
44
.
(01 September 2016)
Commentary
Aging vs. rejuvenation: reprogramming to iPSCs does not turn back the clock for somatic mitochondrial DNA mutations
Stem Cell Investigation
2016;
3:
43
.
(01 September 2016)